Print   Email

Investor Relations

Rockwell Medical is a public company trading on the NASDAQ Exchange under the symbol RMTI.


Recent Releases

Apr 14, 2014
Rockwell Medical Announces Triferic(TM) Iron Replacement Clinical Data Selected for Three Abstract Presentations at National Kidney Foundation Spring Clinical Meetings April 22-26, 2014 in Las Vegas, NV

Mar 24, 2014
Rockwell Medical Submits New Drug Application for Triferic(TM) for the Treatment of Iron Replacement in Chronic Kidney Disease Patients on Hemodialysis

View all releases »

Stock Information
NASDAQ : RMTI
$9.99   - 0.72
Delayed at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.

SFP Mode of Action